Anisa Scott

744 total citations
8 papers, 383 citations indexed

About

Anisa Scott is a scholar working on Molecular Biology, Computational Theory and Mathematics and Cell Biology. According to data from OpenAlex, Anisa Scott has authored 8 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Computational Theory and Mathematics and 2 papers in Cell Biology. Recurrent topics in Anisa Scott's work include Computational Drug Discovery Methods (2 papers), Heat shock proteins research (2 papers) and Fungal Plant Pathogen Control (1 paper). Anisa Scott is often cited by papers focused on Computational Drug Discovery Methods (2 papers), Heat shock proteins research (2 papers) and Fungal Plant Pathogen Control (1 paper). Anisa Scott collaborates with scholars based in United States. Anisa Scott's co-authors include Paul M. Steed, Melanie A Rehder Silinski, James M. Veal, Bradley T. Hyman, Preeti Putcha, Karin M. Danzer, Pamela J. McLean, Carol Hicks, Steven E. Hall and Sarat Chandarlapaty and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Cancer Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Anisa Scott

8 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anisa Scott United States 7 276 88 80 51 40 8 383
Roland G. Heym Germany 10 308 1.1× 43 0.5× 124 1.6× 26 0.5× 43 1.1× 12 488
Mads Nygaard Denmark 8 293 1.1× 49 0.6× 35 0.4× 22 0.4× 20 0.5× 11 425
Matthias J. Knape Germany 11 224 0.8× 45 0.5× 36 0.5× 17 0.3× 26 0.7× 15 340
Yilun Tong China 6 170 0.6× 26 0.3× 33 0.4× 41 0.8× 17 0.4× 6 260
Martina Radli Netherlands 5 331 1.2× 97 1.1× 10 0.1× 32 0.6× 25 0.6× 5 374
Julien Giustiniani France 11 360 1.3× 151 1.7× 15 0.2× 17 0.3× 62 1.6× 13 436
Pinaki Misra United States 11 314 1.1× 35 0.4× 67 0.8× 17 0.3× 24 0.6× 24 446
S.M. Sullivan United States 7 268 1.0× 35 0.4× 72 0.9× 27 0.5× 18 0.5× 9 381
Filippo Favretto Italy 13 326 1.2× 44 0.5× 66 0.8× 7 0.1× 36 0.9× 27 446
Jampani Nageswara Rao United States 8 214 0.8× 77 0.9× 143 1.8× 10 0.2× 47 1.2× 8 423

Countries citing papers authored by Anisa Scott

Since Specialization
Citations

This map shows the geographic impact of Anisa Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anisa Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anisa Scott more than expected).

Fields of papers citing papers by Anisa Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anisa Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anisa Scott. The network helps show where Anisa Scott may publish in the future.

Co-authorship network of co-authors of Anisa Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Anisa Scott. A scholar is included among the top collaborators of Anisa Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anisa Scott. Anisa Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
McMurray, John J.V., Jim Klostergaard, Edmond J. Auzenne, et al.. (2010). 422 Targeting the SH2 domain of Stat3 with phosphopeptide mimetic prodrugs leads to tumor growth inhibition and down-regulation of phosphoTyr705 Stat3 and angiogenic pathways. European Journal of Cancer Supplements. 8(7). 134–134. 3 indexed citations
2.
Putcha, Preeti, Karin M. Danzer, Anisa Scott, et al.. (2009). Brain-Permeable Small-Molecule Inhibitors of Hsp90 Prevent α-Synuclein Oligomer Formation and Rescue α-Synuclein-Induced Toxicity. Journal of Pharmacology and Experimental Therapeutics. 332(3). 849–857. 152 indexed citations
3.
Rice, John W., James M. Veal, Amy F. Barabasz, et al.. (2009). Targeting of Multiple Signaling Pathways by the Hsp90 Inhibitor SNX-2112 in EGFR Resistance Models as a Single Agent or in Combination With Erlotinib. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 18(5). 229–242. 19 indexed citations
4.
Chandarlapaty, Sarat, Ayana Sawai, Qing Ye, et al.. (2008). SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase–Dependent Cancers. Clinical Cancer Research. 14(1). 240–248. 144 indexed citations
5.
Barabasz, Amy F., Briana Foley, James Otto, Anisa Scott, & John W. Rice. (2006). The Use of High-Content Screening for the Discovery and Characterization of Compounds That Modulate Mitotic Index and Cell Cycle Progression by Differing Mechanisms of Action. Assay and Drug Development Technologies. 4(2). 153–163. 23 indexed citations
6.
Steed, Paul M., He Huang, Patrick Fadden, et al.. (2006). 545 POSTER SNX-2112: a novel, selective, potent small molecule inhibitor of Hsp90 with unique pharmacodynamic properties. European Journal of Cancer Supplements. 4(12). 165–165. 6 indexed citations
7.
Burchett, Scott A., Anisa Scott, Beverly Errede, & Henrik Dohlman. (2001). Identification of Novel Pheromone-response Regulators through Systematic Overexpression of 120 Protein Kinases in Yeast. Journal of Biological Chemistry. 276(28). 26472–26478. 15 indexed citations
8.
Scott, Anisa, Clare M.M. Haystead, & Timothy Haystead. (1995). Purification of a 12,020-Dalton Protein That Enhances the Activation of Mitogen-activated Protein (MAP) Kinase by MAP Kinase Kinase. Journal of Biological Chemistry. 270(41). 24540–24547. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026